Activated Allogeneic Lymphocytes for Induction Graft Versus Tumor Effect in Metastatic Solid Tumors

NCT00855452 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer
Malignant Melanoma
Renal Cell Cancer
Gastrointestinal Cancer

Interventions

PROCEDURE: one - three cycles of cell therapy during 4-6 weeks (3-5x10^7 cells/kg will be given through IV systemically

Sponsor

Hadassah Medical Organization